Hydramine and Prevymis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydramine (diphenhydramine hydrochloride) and Prevymis (letermovir). Common drug interactions include dizziness among females and aplastic anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Hydramine and Prevymis. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Hydramine?

Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.

What is Prevymis?

Prevymis has active ingredients of letermovir. eHealthMe is studying from 1,328 Prevymis users. Check the latest studies of Prevymis.



On Jul, 27, 2026

23 people who take Hydramine and Prevymis together, and have interactions are studied.

Hydramine and Prevymis drug interactions.

What are the common drug interactions of Hydramine and Prevymis, by gender? *:

female:

  1. Dizziness
  2. Feeling hot
  3. Pyrexia (fever)
  4. Viral infection
  5. Bacterial infection
  6. Catheter site infection (infection at the site of insertion)
  7. Eye pruritus (eye itching)
  8. Eyelid margin crusting (crusting at the lid margins, generally worse on waking)
  9. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  10. Impaired healing

male:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Mucosal inflammation (infection of mucous membrane)
  4. Pneumonia
  5. Body temperature increased
  6. Fatigue (feeling of tiredness)
  7. Full blood count increased
  8. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  9. Nasopharyngitis (inflammation of the nasopharynx)

What are the common drug interactions of Hydramine and Prevymis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Mucosal inflammation (infection of mucous membrane)

20-29:

n/a

30-39:

n/a

40-49:

  1. Bacterial infection
  2. Blood glucose decreased
  3. Catheter site infection (infection at the site of insertion)
  4. Dizziness
  5. Eye pruritus (eye itching)
  6. Eyelid margin crusting (crusting at the lid margins, generally worse on waking)
  7. Feeling hot
  8. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  9. Impaired healing
  10. Lung disorder (lung disease)

50-59:

  1. Anxiety
  2. Constipation
  3. Cytomegalovirus test positive
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Dyspnoea (difficult or laboured respiration)
  6. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  7. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
  8. Fatigue (feeling of tiredness)
  9. Hypercholesterolaemia (high levels of cholesterol in the blood)
  10. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)

60+:

  1. Bk virus infection
  2. Death
  3. Pericardial effusion (fluid around the heart)
  4. Platelet count decreased
  5. Pleural effusion (water on the lungs)
  6. Post procedural complication
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Tooth abscess (pus formation in tooth)
  9. Viral infection
  10. Weight decreased

What are the existing conditions these people have? *

  1. Thrombocytopenia (decrease of platelets in blood): 7 people, 30.43%
  2. Cytomegalovirus Infection: 7 people, 30.43%
  3. Immunodeficiency Common Variable: 6 people, 26.09%
  4. Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 4 people, 17.39%
  5. Nausea (feeling of having an urge to vomit): 4 people, 17.39%
  6. Immunodeficiency: 4 people, 17.39%
  7. Irritable Bowel Syndrome: 3 people, 13.04%
  8. Febrile Neutropenia (fever with reduced white blood cells): 3 people, 13.04%
  9. High Blood Pressure: 3 people, 13.04%
  10. Hyperglycemia (high blood sugar): 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Hydramine and Prevymis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydramine and Prevymis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prevymis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydramine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prevymis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride and letermovir (the active ingredients of Hydramine and Prevymis, respectively), and Hydramine and Prevymis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: